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Abstract In order to find new antigens from Plasmodium
falciparum, a complementary DNA (cDNA) library was
constructed and screened. The study of expression library of
P. falciparum was performed in an attempt to identify new
antigens that could have potential relevance for the falcipa-
rum-malaria diagnosis and/or protection. Between the posi-
tive clones detected (ring erythrocyte surface antigen,
merozoite erythrocyte surface antigen, RHOP H3, CSP,
LSA), a new gene that correspond to a new protein (Pf62)
was isolated and characterized. This antigen was useful for
the diagnosis of malaria in enzyme-linked immunosorbent
assay tests. The cDNA corresponding to this antigen and
structure of the gene were characterized. Pf62 is a single
copy gene that contains one exon. The Pf62 cDNA has an
open reading frame of 1,599 nucleotides that code for a
putative protein of 532 amino acids with a predicted
molecular mass of 62 kDa. The polypeptide contains in the
central section two regions of repeats of 21 and 19 amino
acids, respectively. The localization of the Pf62 protein was
performed by immunoblot, indirect immunofluorescence
assay and immunoelectron microscopy. Pf62 is localized in
the cytoplasm of the parasite and also on the surface of the
infected erythrocyte. Serologic assays by using synthetic
peptides designed from different antigenic regions of the
Pf62 protein resulted in acceptable data of sensitivity and
specificity in symptomatic malaria patients.
Introduction
Despite more than 100 years of research, malaria remains a
leading cause of morbidity and mortality worldwide.
Although the areas where transmission takes place have
been reduced and confined to the tropical areas, the number
of people at risk has grown to about 3 billion, and it is
expected that this will continue to increase. Not only does
malaria cause around 500 million cases every year and
between 1 and 3 million deaths, it also carries a huge burden
that impairs the economic and social development of large
parts of the planet. The failed attempt to eradicate malaria
gave way to the control policy that was followed by a huge
resurgence of malaria during the late 1970s and 1980s.
Together with the emergence and spread of resistance to
chloroquine and the weak health infrastructure in many of
the endemic countries, particularly in Africa, the malaria
situation worsened worldwide (Guinovart et al. 2006).
Misdiagnosis of malaria results in significant morbidity
and mortality. Rapid, accurate, and accessible detection of
malaria parasites has an important role in addressing this
and in promoting more rational use of increasingly costly
drugs in many endemic areas. The conventional micro-
scopic examination of thin and thick blood films demon-
strates the presence of the parasite. This method is used to
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procedure and relies upon subjective interpretation. To
overcome these limitations, fast and reliable methods for
malaria diagnosis have recently been introduced (Bell et al.
2006). The search of new malaria antigens for rapid
diagnostic technologies (RDTs) is necessary to increase
the number and quality of the field malaria diagnostic tests.
RDTs are mainly based on detect either histidine-rich
protein 2, the parasite-specific lactate deshidrogenase, or
aldolase, which are produced in the erythrocytic cycle.
One of the strategies to search new antigens is the use
immunoscreening of expression libraries to identify Plas-
modium falciparum erythrocytic stage antigens. Several
studies by using this technology have been reported (Kim et
al. 2004; Lobo et al. 1994), and several antigens have been
identify as ring erythrocyte surface antigen (RESA), P.
falciparum asparagine-rich protein, merozoite erythrocyte
surface antigen (MESA), heath shock protein 70 (HSP
70)…. On the other hand, identification of new antigens will
permit to perform protection assays as vaccine candidates.
Although all of the experimental vaccines that are currently
under development are based on approximately 25 parasite
antigens,itnotclear whether theyoverlapwitha subsetorany
of the antigens that induce the most protective naturally
acquired immune responses. Whole genome sequencing has
now provided the complete gene repertoire of P. falciparum
and has opened the way to identify protective antigens
among the approximately 6,000 parasite proteins.
In this study, we have carried out the identification and the
initial characterization of a new protein of P. falciparum. Pf62
antigen was identified from a complementary DNA (cDNA)
expression library of the erythrocytic stages of P. falciparum,
with the aim to increase the arsenal of proteins that could be
used in the development of both new malaria rapid diagnostic
tests as useful tools to malaria diagnosis and possible vaccine
candidates respectively. This manuscript describes the first
approximation to characterization of Pf62, a novel gene
encoding for a protein, which has the potential of being an
efficient antigen for the diagnosis of malaria patients. Due to
the difficulties found to clone and obtain the recombinant
protein, we decide to change the strategy designing synthetic
peptides according to antigenicity index and its posterior
immunization of the rabbits to obtain immune sera. These
sera were used for ultrastructural localization of the Pf62
native protein by immunoelectron microscopy.
Materials and methods
Parasites propagation
P. falciparum Dd2, a clone resistant to chloroquine,
mefloquine, and pirymethamine coming from southeast
Asia and derived from the clone Indochina III/CDC (Guinet
et al. 1996), was maintained in culture in human eryth-
rocytes incubated at 37°C in RPMI 1640 medium supple-
mented with human serum and gas mixture (3% carbon
dioxide, 1% oxygen, and 96% nitrogen). Fresh human
erythrocytes were added at 3 or 4 days interval. The
parasites continued to reproduce in their normal asexual
cycle every 48 h approximately.
Enrichment of parasite-infected red blood cells
by the magnetic method
One milliliter of the 10% suspension of erythrocytes was
applied to a LD column assembled in a magnetic unit
(Miltenyi Biotec) and washed with 20 ml phosphate-buffered
saline (PBS) to remove non-infected erythrocytes and white
blood cells (WBCs). After the effluent from the column
became almost colorless, the magnet was removed, and the
cells retained in the column were eluted with 1 ml PBS.
Thus, the parasite-infected red blood cell (PRBC)-enriched
fraction was obtained. The percentages of PRBCs to total red
blood cells and the ratio of WBCs/PRBCs were determined
on Giemsa-stained blood films (Trang et al. 2004).
Human sera
Sera were supplied by the Parasitology Department, Centro
Nacional de Medicina Tropical, Instituto de Salud Carlos
III, a Reference Laboratory which receives samples from
malaria-suspected patients from different hospitals of Spain.
Two class of sera were used in the study: (a) a mixture of
ten sera from immunofluorescence assay (IFA)-positive
patients (dilution titers ≥1/1,024) was used for immuno-
screening of the cDNA library and (b) 174 sera classified in
the following: 110 sera of the whole were from individuals
with IFA and PCR confirmed malaria, 30 sera from
individuals with other parasitic diseases confirmed by
serological methods (leishmaniasis (n=10), Chagas disease
(n=10), toxoplasmosis (n=10)), and 34 negative control
sera from Spanish healthy individuals without contact with
endemic areas. Negative controls were used in order to
establish suitable cut-off values for the serological assays.
Study was approved by the Ethic Committee of the Instituto
de Salud Carlos III.
Extraction of genomic DNA
P. falciparum genomic DNA (gDNA) was isolated from
blood-stage parasites (strain Dd2) cultured in vitro. The
parasites were resuspended with 400 μl of extraction buffer
(100 mM Tris–HCl, pH 7.4, 100 mM NaCl, 10 mM EDTA,
pH 8.0). Then, 1% SDS, K-Proteinase was added and
incubated for 2 h at 55°C. After incubation, RNAse
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volume of potassium acetate was added and incubated in
ice for 55 min. The DNA was extracted and precipitated
with phenol/chloroform and ethanol, respectively. The
pellet was resuspended in Milli-Q sterile water (Millipore),
the DNA concentration was determined by a spectropho-
tometer, and the samples were stored at −20°C.
cDNA expression library
Total RNA was prepared as previously described (Rangel-
Aldao et al. 1987) from P. falciparum erythrocytic stages.
Messenger RNA (mRNA) was extracted as described by
Avid and Leder (1972). A sample containing 2.2 μgo f
mRNA was converted into double-stranded cDNA with the
ZAP Express cDNA synthesis kit (Stratagene, CA, USA)
according to the manufacturer’s instructions and then
ligated to the ZAP expression vector employing λ-ZAP
Express library kit (Stratagene). The original library was
amplified containing 4.2×10
8 pfu/ml and 31% of non-
recombinant phage.
Isolation and sequence analysis of P. falciparum Pf62
cDNA
cDNA library was screened using equal volumes of a pool
of malaria positive sera. Clones of RESA, RHOP H3, HSP
70, MESA, LSA, and CSP recombinant antigens were
detected. One positive clone (Pf62) was purified by
repeated cycles of immunoscreening. Recombinant pBK-
CMV plasmids were excised from positive phages. The size
of the Pf62 positive clone was determined by PCR using T3
and T7 universal primers and EcoRI/XhoI double digestion.
The nucleotide sequence was determined by the dideoxy
method (Sanger et al. 1977) using the Big-Dye Terminator
Cycle Sequencing Ready Reaction Kit (PerkinElmer,
Langen, Germany) and an Applied Biosystems 377 DNA
sequencer (Perkin Elmer); however, the clone lacked 5′ and
3′ ends. Thus, in order to obtain a complete cDNA
sequence, the 5′ and 3′ ends were amplified by PCR using
specific primers based on the genomic DNA sequence of
the clone 3D7 P. falciparum provided by the PlasmoDB
database. We used the following primers: the forward
primer Pf62 FULL START (5′GAGAGAGACCCGGGAT
GATGGAAGG 3′) and reverse primer Pf62 FULL STOP
(5′ GAGAGAGACTCGAGTTAATTAAATACAG 3′). To
amplify the complete sequence of P. falciparum Pf62,
genomic DNA extraction was carried out based on the
method described above from cultures of Dd2 clone. The
amplified product of 1,599 bp (Genbank accession no. AJ
493426) and the predicted amino acid sequence compar-
isons were carried out with the EMBL and SWISS-PROT
databanks using software packages from Genetic Computer
Group (Devereux et al. 1984). The bioinformatic program
Genscan of the Genemachine server (Makalowska et al.
2001) was used to predict a possible open reading frame
(ORF) and the organization of the Pf62 gene. Prosite
(Bucher and Bairoch 1994) and Psipred (Jones 1999)
bioinformatic programs were used to study functional
motifs and to predict the secondary structure of Pf62
protein. The primers were synthesized by Roche Molecular
Biochemicals, Barcelona, Spain. The PCR experiments
were performed on a GeneAmp PCR System 2400 (Perkin
Elmer, NJ, USA).
Southern blotting, labeling, and hybridization procedures
Aliquots of P. falciparum gDNA (0.5 μg/digestion)
prepared as described previously (Sambrook et al. 1989)
were digested completely with various restriction endonu-
cleases, AluI, ApoI, EcoRI, HindIII, HinfI, and SspI
(Roche Diagnostics), according to the manufacturer’s
instructions. The digested DNA samples were visualized
by electrophoresis in 0.8% agarose gels and transferred to
positively charged nylon membranes (Hybond nylon
+,
Amersham) as described (Maniatis et al. 1982). The Pf62
incomplete cDNA probe was labeled with digoxigenin-11-d
UTP (Roche Diagnostics) by random primer method,
according to the manufacturer’s instructions. The labeled
probe was incubated under high-stringency conditions at
65°C. After hybridization, the filter was washed in 5×
SSC, 0.1% N-lauryl sarcosine, 0.02% SDS, and 1×
blocking reagent (Roche Diagnostics) at 65°C for
10 min. A second wash was done in 0.2× SSC and 0.1%
SDS at 65°C for 40 min. The immunodetection was
carried out with antidigoxigenin conjugated with alkaline
phosphatase, and the immune complexes were visualized
using the chemiluminescence substrate CSPD (Roche
Diagnostics) on X-ray film (Amersham), with an intensi-
fying screen at room temperature for 15 min, as described
by the manufacturer’s instructions.
Synthesis of peptides derived from Pf62 deduced amino
acid sequence
The difficulties found to express the whole protein made us
use the strategy of synthesizing synthetic peptides to
serological studies. Taking into account the full length of
the Pf62 deduced amino acid sequence; three peptides were
designed according to the Jameson–Wolf antigenicity index
(Jameson and Wolf 1988). The peptides were synthesized by
the Institute of Health Carlos III, and their sequences were as
follows: Pf62 ZR 273PQAEKDASKLTTTYDQTKEVK292,
repeated three times in the sequence, Pf62 ZR1 315PQAEK
DALAKTENQNGELL333, repeated two times in the se-
quence and Pf62 ZR2 374PQAEKDALAKTENQSGELL392.
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Peptides Pf62 ZR, Pf62 ZR1, and Pf62 ZR (0.2 μg/ml,
100 μl/well) were diluted in coating buffer (0.1 M
carbonate/bicarbonate pH 9.6) and then used to coat 96
well plates (Maxisorp® 2, flat bottom, Nunc) overnight at
4°C. Unbound antigen was removed by washing the wells
with PBS, pH 7.3 containing 0.05% (w/v) Tween® 20.
After washing, 100 μl of experimental serum samples
(diluted 1/100) per well was added an incubated for 1 h at
37°C. Each sample was run in duplicate. After washing,
100 μl per well of goat antihuman IgG conjugated with
peroxidase (H and L chains Pierce®) diluted 1/5,000 were
added and incubated for 1 h at 37°C. The plates were
washed, and 100 μl/well of substrate (ABTS in 10 ml
citrate–phosphate–perborate buffer) was added, and the
plates were incubated for 15 min at room temperature. The
optical density was read at 405 nm on a microplate reader
(Mios, Merk®). A sample was considered positive if the
specific absorbance was greater than the cut-off values. The
cut-off value was obtained with the mean value of 34
negative serum samples plus three standard deviations
(SD). Cut-off values: Pf62 ZR=0.195.
Preparation of rabbit Pf62-specific antiserum
Two 3-month-old female New Zealand White rabbits were
immunized by subcutaneous injection of 120 μg of Pf62
ZR peptide conjugated to ovalbumin and to KLH (Keyhole
limpet hemocyanin; Pierce®) carriers in Freund’s complete
adjuvant (Difco®). Before the first immunization, 10 ml
was obtained from each rabbit as negative control. Animals
were boosted two times with 120 μg of Pf62 ZR peptide
conjugated to the carriers in Freund’s incomplete adjuvant
(Difco®) 6 weeks postinjection by intramuscular injections.
Fifteen days after the third immunization, the animals were
bled. The serum obtained is referred to as anti-Pf62. The
serum titer was determined by enzyme-linked immunosor-
bent assay (ELISA).
SDS-PAGE and western blot analysis
One-dimensional sodium dodecyl sulfate–10% polyacryl-
amide gel electrophoresis (SDS–10% PAGE) and western
blotting of P. falciparum Dd2 clone protein extract (20 μg)
were carried out. The separated proteins were transferred to
nitrocellulose membranes (Schleicher & Schuell, Protran®)
with a semidry blotting apparatus (Trans-blot® SD Semi-
dry, Bio-Rad®) during 30 min at 10 V. The filters were
blocked with PBS containing 3% BSA at 4°C, overnight.
During the next day, they were rinsed in PBS containing
0.05% (w/v) Tween® 20 and incubated with anti-Pf62
polyclonal rabbit antiserum diluted 1/50 in the blocking
solution for 1 h at room temperature. After washing, goat
antirabbit IgG conjugated to peroxidase (H and L chains;
Pierce) diluted 1/5,000 was added and incubated for 1 h at
room temperature. The nitrocellulose membrane was
washed, and the reaction was developed with DAB
substrate diluted in peroxide buffer (Pierce®) as described
by the manufacturer’s instructions.
Indirect immunofluorescence assay
Smears of RBC infected with P. falciparum clone Dd2 were
fixed with ice-cold 100% acetone for 5 min and incubated
with rabbit anti-Pf62 polyclonal antiserum (diluted 1/50 in
PBS-BSA), 1 h at 37°C. After, this smears were washed
with 3% (w/v) BSA (Sigma) diluted in PBS. As secondary
antibody, we used goat antirabbit IgG labeled with
fluorescein (Pierce) diluted 1/500 and incubated for
50 min at 37°C in blocking solution with Evans Blue
0.05%. After washing, 10 μg/ml propidium iodide diluted
in mounting solution (glycerol/PBS pH 9.2) was added in
order to label the DNA. Dual color fluorescence images
were captured using a Zeiss Axioskop (Zeiss®) fluores-
cence microscope.
Immunoscanning electron microscopy
The immunolocalization SEM procedures were performed
as described elsewhere (Herrera et al. 1998) Briefly, red
blood cells uninfected or infected with P. falciparum were
subjected to a series of washings (PBS + 0.13% NaN3 +1 %
BSA + 1% AB human serum as washing buffer) and
incubations with antibodies (PBS + 0.13% NaN3 +5 %
BSA + 4% AB human serum as incubation buffer),
collecting the samples in between by centrifugation
(230×g, 10 min, 21°C). Rinsed samples were incubated
with 100 μl of the primary antibody (anti-Pf62 rabbit
specific antiserum diluted 1/10 in incubation buffer) for
30 min at room temperature. After rinsing (three times) in
washing buffer, the samples were incubated with 100 μlo f
a secondary antibody for gold labeling (goat antirabbit IgG
coupled to 30-nm-diameter colloidal gold particles—
Amersham Pharmacia-Biotech—diluted 1/10 in incubation
buffer) at room temperature for 60 min. After two washings,
the samples were fixed with 2% glutaraldehyde–0.1 M
sodium cacodylate buffer–pH 7.4 for 1 h at 4°C and rinsed
with chilled 0.1 M sodium cacodylate buffer–pH 7.4
supplemented with 4.5% saccharose. The cells were then
dehydrated in a graded ethanol series, mounted onto
formvar-carbon-coated 400-mesh electron microscopy nick-
el grids using poly-L-lysine, dried in a critical point dryer
(Balzer 030 CPD), and coated with a 15-nm carbon layer in
a high vacuum coating unit (Balzers 080). The samples
were analyzed in SEM mode under a CM-12 TEM/STEM
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electron (SE) and backscattered electron (BSE) detectors.
Immunotransmission electron microscopy
For the immunogold detection of the Pf62 proteins on
ultrathin sections, the cells were fixed in 2% paraformal-
dehyde, 0.2% glutaraldehyde in 0.1 M sodium cacodylate
buffer, 60 min at 4°C, rinsed (2×30 min) in chilled 0.1 M
sodium cacodylate buffer supplemented with 4.5% saccha-
rose, and treated for low temperature embedding in
hydrophilic acrylic resin (Lowicryl K4 M—Polyscience,
Warrington, PA, USA) in order to preserve the antigen
properties. Briefly, the samples were dehydrated starting
with 50% ethylene glycol at 0°C and following by a graded
ethanol (50%–90%) series at −35°C, embedded in graded
ethanol 90%/Lowicryl series until pure Lowicryl resin and
polymerized with a UV light at −35°C and at room
temperature. Ultrathin sections, obtained with a ultramicro-
tome (Ultratome, LKB), were mounted on 400 mesh nickel
grids and processed for immunogold-labeling at room
temperature, blocked (three times) in 100 μl drops of
blocking buffer (TBS (10 mM Tris–HCl, 9 mg/ml NaCl;
pH 7.4), 0.2 mg/ml NaN3, 0.1% Tween 20; 20 mg/ml
BSA), incubated 60 min on a 10 μl drop of primary
antibodies (anti-Pf62 rabbit specific antiserum, 1/5,000 in
blocking buffer), washed (three times) in 100 μl drops of
washing buffer (TBS–NaN3–Tween; 2 mg/ml BSA), incu-
bated 60 min on 10 μl drops of secondary antibodies (goat
antirabbit IgG coupled to 10-nm-diameter colloidal gold
particles—Biocell Amersham Pharmacia-Biotech—diluted
1/10 in washing buffer) and three times washing (washing
buffer + 0.1% Triton X-100) plus three times washing in
double-distilled water. To contrast the sections, uranyl
acetate (1% in dd water) was used. The samples were
analyzed in TEM mode under a CM-12 TEM/STEM
Philips electron microscope.
Results
Identification and analysis of P. falciparum Pf62 cDNA
To identify novel antigen genes, a screening of 5×
10
4 clones from the P. falciparum cDNA library with a
pool of malaria patients sera yielded 35 promising signals.
Of these, one molecule of 1.12 kb (Pf62) was sequenced
and further characterized. This cDNA sequence had an
incomplete open reading frame. In order to obtain the
complete Pf62 sequence, a PCR was designed using
standard PCR protocols, parasite gDNA, and primers were
derived from both the 5′ and 3′ ends of the DNA sequence
provided by Genbank database (Pf62 FULL STAR and
Pf62 FULL STOP, Fig. 1). A variety of PCRs were carried
out, and in all them, a band of 1.59 kb was obtained
(Fig. 1). The sequencing of the fragment revealed the full
Pf62 open reading frame sequence of 1,599 bp (Fig. 1). The
ORF was coded for a putative protein of 532 amino acid
residues with 62 kDa theorical molecular mass and an
isoelectric point of 5.53 (Genbank accession no. AJ
493426). The Pf62 primary structure amino acid sequence
can be separated into three different linear domains: (1)
amino-terminal domain, (2) central domain, and (3)
carboxy-terminal domain. The central domain contains
two regions of repeats of 21 and 19 amino acids,
respectively. The first region contains three repeats with a
consensus sequence: PQAEKDASKLTTTYDQTKEVK
(positions 273–314 and 334–354). The second region
contains three imperfect repeats with a consensus sequence:
PQAEKDALAKTENQN/SGELL (positions 315–333 and
355–392). Using the bioinformatic program Prosite, various
putative N-glycosylation sites of the Pf62 protein were
identified in the residues 5, 368, 417, 444, and 451. The
study of the predicted secondary structure using the Psipred
program revealed that Pf62 was a hydrophilic protein rich
α-helices and without β-sheets.
Fig. 1 Representation of genomic organization of the Pf62 gene. The
gene for Pf62 is located on chromosome 9 of strain 3D7 P. falciparum.
The Pf62 gene sequence consists of one exon in the 3D7 and Dd2
strains. The partial sequence of the clone obtained in the immuno-
screening corresponds to 252–1,377 bp or Pf62 gene. The primers
used for genomic PCR (Pf62 FULL STAR and Pf62 FULL STOP) are
designed on the sequence at the beginning and the end of the Pf62
gene. The size of fragments (base pair) is indicated. iMet-ATG,
termination codon-TAA, and polyadenylation signal-AAATAAA
positions are marked. The boxes in different colors correspond to the
repeats regions
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predicted amino acid sequence with the Genbank/EMBL
and SWISS-PROT databanks did not show any similarity
with sequences described in the databases.
Organization of the Pf62 gene
Pf62 gene was located in the chromosome 9 of P. falciparum
genome. The comparison of the Pf62 cDNA with the
homologous DNA sequence provided by the PlasmoDB
database revealed that the full P. falciparum Pf62 genomic
sequence spans approximately 2 kb, with single exon and
without introns. The locations of translation star codon
(iMet), poly (a)-tail signals and stop codon are shown in the
Fig. 1. These results were confirmed by the bioinformatic
program Genscan. When Southern analysis was carried out
with P. falciparum gDNA digested by AluI, ApoI, EcoRI,
HindIII, HinfI, and SspI, using the Pf62 cDNA as a probe,
the hybridization patterns obtained suggested that the Pf62
gene is a single copy gene (Fig. 2a). This result is
consistent with the only presence of a homologous DNA
sequence in the chromosome 9 from clone 3D7 P.
falciparum (PlasmoDB database). Further more, nucleotide
polymorphisms were observed among both sequences.
Localization of Pf62 native protein in extract cultures
from P. falciparum
The rabbit anti-Pf62 antiserum identified a 62 kDa protein
on Western/blot analysis using extracts cultures from clon
Dd2 P. falciparum (Fig. 2b). This antiserum was then used
to localize the Pf62 native protein in cellular and subcel-
lular studies.
Cellular localization of Pf62 native protein
The cellular localization of Pf62 was examined by indirect
IFA. To determine the cellular localization of Pf62, IFA was
performed on cultures containing rings, trophozoites and
schizonts stages parasites (Dd2 clone). The rabbit antiserum
against Pf62 localized the native protein in all the stages. The
fluorescence was clearly and preferentially localized on the
surface as well as in the cytoplasm of infected erythrocytes
(Fig. 3). The IFAwas repeated using rabbit anti-Pf62 serum at
multiple dilutions (1:10–1:1,000) with identical results. The
preimmune serum, used as a control, was negative in IFA.
Ultrastructural localization of the Pf62 native protein
by immunoelectron microscopy
Immunotransmission electron microscopy (immuno-TEM)
was used to analyze the ultrastructural localization of the
Pf62 antigen. All the rabbit antisera prepared against
recombinant peptide derived of the Pf62 protein repetitive
domain reacted with ultrathin sectional material (the PRBC-
enriched fraction) containing asexual stages of the Dd2
clone, while the preimmune serum, used as control, gave a
negative result. The gold particles were distributed by the
parasite’s cytoplasm and by the infected erythrocyte
(Fig. 4), indicating the presence of the Pf62 protein of P.
falciparum and confirming the IFA results but providing a
more detailed analysis and an ultrastructural localization
due to the higher resolution of the EM. This also suggests
that these antibodies have the potential to recognize the
Pf62 protein in its natural form and that they could be used
in capture assays for the diagnosis of malaria.
In the present work, the immunoscanning electron
microscopy (immuno-SEM) was carried out using the
PRBC-enriched fraction and reveals the localization of the
Pf62 protein on the outer surface membrane of the infected
erythrocyte. The design of the used electron microscope
permits to obtain at the same time the SE image of the cells
showing their ultrastructure and the BSE-image that
illustrates the distribution of the gold particles and therefore
the localization of the Pf62 antigen against in which the
primary antibodies were specifically raised (Fig. 5).
Immunogenicity of synthetic peptide constructs evaluated
by ELISA
The difficulties found in the expression of the Pf62 protein
made us change strategy and develop synthetic peptides. To
Fig. 2 Restriction, hybridization analyses, and expression of Pf62 in
Dd2 strain P. falciparum from total DNA and extracts cultures
respectively. a The P. falciparum gDNA (0.5 μg/lane) digested with
AluI( lane1), ApoI( lane 2), EcoRI (lane 3), HindIII (lane 4), and HinfI
(lane 5) were electrophoresed on 0.8% (w/v) agarose gel, blotted, and
hybridized to the digoxigenin-11-dUTP-labeled incomplete
Pf62 cDNA insert. b Protein samples (20 μg) were charged in each
lane, fractionated in 10% polyacrylamide gel, transferred to nitrocel-
lulose membrane, and probed with specific antisera against the Pf62
protein (lane 2) and preimmune sera (lane1). The molecular markers
positions are indicated on the left kilodaltons (prestained SDS-PAGE
standards, broad range; Biorad®)
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protein of P. falciparum, the polyclonal antibodies obtained
from rabbits immunized with different peptides corre-
sponding to repeat sequences of Pf62 were tested by ELISA.
The experimental animals, immunized rabbits, produced
specific antibodies against one of the Pf62 peptide constructs
(Pf62 ZR). The results with the other peptides (Pf62 ZR1
and Pf62 ZR2) were negatives. In the present study, we
explored the potential of synthetic peptide (Pf62 ZR) for
usage in the diagnosis of malaria. When sera from malaria
seropositive individuals to malaria were examined by ELISA
for antibodies using Pf62 ZR peptide as antigen, the assay
sensitivity was 59%; however, using sera from symptomatic
malaria patients, the sensitivity reached 70%. When the Pf62
peptide was tested with sera from patients with other
parasitic diseases as leishmaniasis, Chagas disease, and
toxoplasmosis, specificities of 100% were obtained.
Discussion
In this work, an expression library of P. falciparum
erythrocytic stages was performed in an attempt to identify
new antigens that could have potential relevance in
immunodiagnosis and immunoprophylaxis of malaria. In
effect, various examples have been reported in the literature
about the immunoscreening of a P. falciparum spp.
Expression libraries have been a tool used by others authors
in order to identify useful antigens for the diagnosis of
malaria patients as well as to see the usefulness in
protection (Kim et al. 2004; Zhang et al. 1999; Lobo et
al. 1994). We report the identification and characterization
of the Pf62 gene that encoded a putative protein of 532
amino acids with two regions of repeats of 21 and 19 amino
acids in the central region of the molecule. In fact, P.
falciparum contains polypeptides with extensive sequence
repeats and is sometimes extraordinary Kemp et al. (1990).
These repeats are immunodominant in the sense that much
of the human antibody response is directed against them. It
has been observed that not many immune individuals have
got very high levels of antibodies against many repetitive
antigens. In addition, to the repetitive epitopes, P. falcipa-
rum encodes an enormous number of cross-reactive
epitopes, which are also postulated to be responsible for
the immune evasion (Anders 1986). The remarkable level
of antigenic diversity among different strains of P.
Fig. 4 Ultrastructural localization of Pf62 protein in different stages
of P. falciparum. Transmission electron microscopy immunogold-
labeling (10 nm gold particles, arrows) in ultrathin sections. a General
overview of parasite-infected RBCs (×6,300, original magnification).
b The Pf62 protein is localized in the trophozoite and in the
erythrocyte, both in the cell interior and surface. c The same
trophozoite at higher magnification
Fig. 3 Localization of the anti-Pf62 reactivity on asexual parasite
stages by indirect immunofluorescence. Smears of parasite-infected
red blood cells, strain Dd2, were reacted with rabbit anti-Pf62
polyclonal antisera. a Incubation with 1:50 dilution of antisera raised
against the Pf62 protein. b Incubation with preimmune rabbit serum at
the same dilution, derived from the same rabbit used to derive Pf62
antibodies prior to the first immunization
Parasitol Res (2009) 104:1389–1397 1395falciparum (Fenton et al. 1985; Tait 1981) reflects, at least
in part, the repeat structure of these antigens.
Western-blot analysis using anti-Pf62 antiserum localized
the native antigenic protein of 62 kDa in extract cultures from
P. falciparum. This antiserum was then used to localize the
Pf62 native protein in cellular and subcellular studies by IFA,
immuno-SEM, and immuno-TEM. All three methods
showed the same tendency: Pf62 native protein was
distributed by the parasite’s cytoplasm and also on the
surface membrane of the infected erythrocyte. There is
considerable information available in literature concerning
the disposition of parasite proteins in host cell plasma
membranes. However, this information is confusing and
conflicting (Wunderlich et al. 1988a, b). In truth, we do not
know if the Pf62 protein is accessible from the outside in
intact P. falciparum-infected erythrocytes because the host
cell plasma membranes are artificially changed. This indicate
that drying and fixing with acetone and/or ethanol induce
changes in membrane organization, which make accessible
parasite proteins normally buried in host cell plasma
membranes (Wunderlich et al. 1988a). Therefore, the Pf62
protein could have cryptic disposition in intact host cell
plasma membranes of P. falciparum-infected erythrocytes.
Finally, in the present study, we explored the potential
of three peptides derived from the Pf62-deduced amino
acid sequence for usage in the diagnosis of malaria. The
peptides were designed in highly antigenic and repeated
regions of Pf62. The peptide Pf62 ZR showed the best
results when it was used in ELISA assays with a
sensibility of 70% in symptomatic malaria patients and
a specificity of 100%. Also, the experimental animals,
immunized rabbits, produced specific antibodies against
one of the Pf62 peptide constructs (Pf62 ZR). The results
with the other peptides (Pf62 ZR1 and Pf62 ZR2) were
negatives. It is very important to underline that the
immunogenic capacity of a peptide not only depends on
intrinsic chemical properties of the peptide but also on
many complex interactions with various elements of the
host immune system, such as the host immunoglobulin
repertoire, self-tolerance, and various cellular and regula-
tory mechanisms definable only in the context of the host
(Van Regenmortel 2001). Also, the high specificity
showed the Pf62 ZR peptide is very important for the
diagnosis because of the people living in malaria
endemic areas with acquire immunity against malaria
responded positively to all the malarial immunogens
tested; however, the same persons also showed low
specificity (Mannan et al. 2003). Besides, the Pf62 ZR
peptide could be used to assess malaria transmission in
epidemiological surveys similar to the studies carried out
for Ferreira-da-Cruz et al. (1995). This study evaluated the
antibody responses to P. falciparum sporozoite-, liver-, and
blood-stage synthetic peptides in different populations in
malaria endemic areas. On the other hand, the polyclonal
antibodies against the Pf62 ZR peptide will be used for the
development of diagnostic tests based on the capture of
antigens. Some authors have studied the immunogenicity of
synthetic peptides derived from P. falciparum proteins to
obtain specific antibodies suitable to be used in an antigen-
capture assay (Zerpa et al. 2006).
In conclusion, this report describes the first approxima-
tion to characterization of Pf62, a new P. falciparum
antigen that could be, if it is confirmed in further studies,
a candidate for malaria diagnosis or malaria protection.
Acknowledgments This study was financially supported by the
Spanish Ministry of Public Health and the Instituto de Salud Carlos III
within the Network of Tropical Diseases Research Centers (RICET-
RD06/0021) by a grant from Centro Nacional de Medicina Tropical,
Instituto de Salud Carlos III. None of the authors has any conflict of
interest to declare.
Fig. 5 Immunoscanning elec-
tron micrograph. Erythrocytes
parasite-infected by P. falcipa-
rum. Left The backscattered
electron detector identifies the
bright signals from the gold
particles that localize the Pf62
protein. Right The same field
using the secondary electron
detector that shows the ultra-
structure of the erythrocytes
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